Analgesic Effect of the Newly Developed S(+)-Flurbiprofen Plaster on Inflammatory Pain in a Rat Adjuvant-Induced Arthritis Model

作者：Sugimoto Masanori^*; Toda Yoshihisa; Hori Miyuki; Mitani Akiko; Ichihara Takahiro; Sekine Shingo; Hirose Takuya; Endo Hiromi; Futaki Nobuko; Kaku Shinsuke; Otsuka Noboru; Matsumoto Hideo

来源：Drug Development Research, 2016, 77(1): 20-28.

DOI：10.1002/ddr.21288

• S(+)-flurbiprofen
• analgesic
• nonsteroidal anti-inflammatory drugs

This article describes the properties of a novel topical NSAID (Nonsteroidal anti-inflammatory drug) patch, SFPP (S(+)-flurbiprofen plaster), containing the potent cyclooxygenase (COX) inhibitor, S(+)-flurbiprofen (SFP). The present studies were conducted to confirm human COX inhibition and absorption of SFP and to evaluate the analgesic efficacy of SFPP in a rat adjuvant-induced arthritis (AIA) model. COX inhibition by SFP, ketoprofen and loxoprofen was evaluated using human recombinant COX proteins. Absorption of SFPP, ketoprofen and loxoprofen from patches through rat skin was assessed 24 h after application. The AIA model was induced by injecting Mycobacterium tuberculosis followed 20 days later by the evaluation of the prostaglandin PGE(2) content of the inflamed paw and the pain threshold. SFP exhibited more potent inhibitory activity against COX-1 (IC50=8.97 nM) and COX-2 (IC50=2.94 nM) than the other NSAIDs evaluated. Absorption of SFP was 92.9%, greater than that of ketoprofen and loxoprofen from their respective patches. Application of SFPP decreased PGE(2) content from 15 min to 6 h and reduced paw hyperalgesia compared with the control, ketoprofen and loxoprofen patches. SFPP showed analgesic efficacy, and was superior to the ketoprofen and loxoprofen patches, which could be through the potent COX inhibitory activity of SFP and greater skin absorption. The results suggested SFPP can be expected to exert analgesic effect clinically.

• 出版日期2016-2